{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T17:04:15Z","timestamp":1763744655673},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.atherosclerosis.2011.09.028","type":"journal-article","created":{"date-parts":[[2011,9,22]],"date-time":"2011-09-22T05:15:43Z","timestamp":1316668543000},"page":"413-417","source":"Crossref","is-referenced-by-count":30,"title":["Genetic variation at the SLCO1B1 gene locus and low density lipoprotein cholesterol lowering response to pravastatin in the elderly"],"prefix":"10.1016","volume":"220","author":[{"given":"Hironobu","family":"Akao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliana","family":"Polisecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouji","family":"Kajinami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stella","family":"Trompet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Ford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Wouter","family":"Jukema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton J.M.","family":"de Craen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudi G.J.","family":"Westendorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Packard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan M.","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernst J.","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2011.09.028_bib0005","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/jama.298.7.776","article-title":"Clinical utility of different lipid measures for prediction of coronary heart disease in men and women","volume":"298","author":"Ingelsson","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2011.09.028_bib0010","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.09.028_bib0015","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.clpt.2006.06.010","article-title":"SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin","volume":"80","author":"Niemi","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.atherosclerosis.2011.09.028_bib0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00210-006-0053-6","article-title":"Influence of the SLCO1B1*1b and *5 haplotypes on pravastatin's cholesterol lowering capabilities and basal sterol serum levels","volume":"373","author":"Gerloff","year":"2006","journal-title":"Naunyn Smiedebergs Arch Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2011.09.028_bib0025","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.clpt.2006.01.010","article-title":"Impact of the SLCO1B1 polymorphism on the pharmacokinetics and lipid-lowering efficacy of multiple-dose pravastatin","volume":"79","author":"Igel","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.atherosclerosis.2011.09.028_bib0030","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1365-2125.2006.02643.x","article-title":"Pharmacokinetics and response to pravastatin in paediatric patients with familial hypercholesterolaemia and in paediatric cardiac transplant recipients in relation to polymorphisms of the SLCO1B1 and ABCB1 genes","volume":"61","author":"Hedman","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2011.09.028_bib0035","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2133\/dmpk.19.375","article-title":"Effect of genetic polymorphism of OATP-C (SLCO1B1) on lipid-lowering response to HMG-CoA reductase inhibitors","volume":"19","author":"Tachibana-Iimori","year":"2004","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.atherosclerosis.2011.09.028_bib0040","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/sj.tpj.6500328","article-title":"An association study of 43 SNPs in 16 candidate genes with atorvastatin response","volume":"5","author":"Thompson","year":"2005","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.atherosclerosis.2011.09.028_bib0045","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2217\/14622416.9.9.1217","article-title":"Association between a frequent allele of the gene encoding OATP1B1 and enhanced LDL-lowering response to fluvastatin therapy","volume":"9","author":"Couvert","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.atherosclerosis.2011.09.028_bib0050","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMoa0801936","article-title":"SLCO1B1 variants and statin-induced myopathy \u2013 a genomewide study","volume":"359","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2011.09.028_bib0055","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.jacc.2009.04.053","article-title":"The SLCO1B1*5 genetic variant is associated with statin-induced side effects","volume":"54","author":"Voora","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2011.09.028_bib0060","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"PROspective Study of Pravastatin in the Elderly at Risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2011.09.028_bib0065","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0002-9149(99)00533-0","article-title":"The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk","volume":"84","author":"Shepherd","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2011.09.028_bib0070","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.addr.2010.07.006","article-title":"Functional crosstalk of CAR-LXR and ROR-LXR in drug metabolism and lipid metabolism","volume":"62","author":"Xiao","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.atherosclerosis.2011.09.028_bib0075","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0022-2275(20)38697-1","article-title":"A rapid micromethod for apolipoprotein E phenotyping directly in serum","volume":"28","author":"Havekes","year":"1987","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2011.09.028_bib0080","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1093\/clinchem\/42.11.1817","article-title":"Frequency of phenotype-genotype discrepancies at the apolipoprotein E locus in a large population study","volume":"42","author":"Lahoz","year":"1996","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2011.09.028_bib0085","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0021-9150(94)05439-P","article-title":"Effect of apolipoprotein E and A-IV phenotypes on the low density lipoprotein response to HMG CoA reductase inhibitor therapy","volume":"113","author":"Ordovas","year":"1995","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2011.09.028_bib0090","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0021-9150(01)00410-5","article-title":"Apolipoprotein E genotype affects plasma lipid response to atorvastatin in a gender specific manner","volume":"158","author":"Pedro-Botet","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2011.09.028_bib0095","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1161\/01.ATV.16.10.1250","article-title":"Apolipoprotein E alleles and risk of coronary disease: a meta-analysis","volume":"16","author":"Wilson","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2011.09.028_bib0100","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0021-9150(00)00570-0","article-title":"Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study","volume":"154","author":"Lahoz","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2011.09.028_bib0105","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/genetics\/50.4.757","article-title":"The interaction of selection and linkage. II. Optimum models","volume":"50","author":"Lewontin","year":"1964","journal-title":"Genetics"},{"key":"10.1016\/j.atherosclerosis.2011.09.028_bib0110","doi-asserted-by":"crossref","unstructured":"Expert panel executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486\u201397.","DOI":"10.1001\/jama.285.19.2486"},{"key":"10.1016\/j.atherosclerosis.2011.09.028_bib0115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.atherosclerosis.2007.12.004","article-title":"Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPER","volume":"200","author":"Polisecki","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2011.09.028_bib0120","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.atherosclerosis.2007.12.005","article-title":"Genetic variation at the PCSK9 locus moderately lowers low-density lipoprotein cholesterol levels, but does not significantly lower vascular disease risk in an elderly population","volume":"200","author":"Polisecki","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2011.09.028_bib0125","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1194\/jlr.P001172","article-title":"Genetic variation at the NPC1L1 gene locus, plasma lipoproteins, and heart disease risk in the elderly","volume":"51","author":"Polisecki","year":"2010","journal-title":"J Lipid Res"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915011009348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915011009348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T01:55:36Z","timestamp":1638755736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915011009348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0021915011009348"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.09.028","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}